craft-sa-dev Home  

PMC:1584416 / 1900-2523 JSONTXT 5 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T565 0-12 JJ denotes Interallelic
T566 13-28 NN denotes complementation
T568 29-31 VBZ denotes is
T567 32-39 VBN denotes defined
T569 40-42 IN denotes as
T570 43-46 DT denotes the
T571 47-54 NN denotes ability
T572 55-57 IN denotes of
T573 58-61 CD denotes two
T575 62-76 RB denotes differentially
T576 77-84 VBN denotes mutated
T574 85-92 NNS denotes alleles
T577 93-95 TO denotes to
T578 96-104 VB denotes function
T579 105-111 RBR denotes better
T580 112-120 RB denotes together
T581 121-125 IN denotes than
T583 126-132 DT denotes either
T582 133-136 MD denotes can
T584 137-139 IN denotes on
T585 140-143 PRP$ denotes its
T586 144-147 JJ denotes own
T587 147-148 . denotes .
T588 148-295 sentence denotes Despite its near universality in lower organisms [1], its potential to contribute to clinical heterogeneity in human disease is seldom considered.
T589 149-156 IN denotes Despite
T591 157-160 PRP$ denotes its
T593 161-165 JJ denotes near
T592 166-178 NN denotes universality
T594 179-181 IN denotes in
T595 182-187 JJR denotes lower
T596 188-197 NNS denotes organisms
T597 198-199 -LRB- denotes [
T598 199-200 CD denotes 1
T599 200-201 -RRB- denotes ]
T600 201-203 , denotes ,
T601 203-206 PRP$ denotes its
T602 207-216 NN denotes potential
T603 217-219 TO denotes to
T604 220-230 VB denotes contribute
T605 231-233 IN denotes to
T606 234-242 JJ denotes clinical
T607 243-256 NN denotes heterogeneity
T608 257-259 IN denotes in
T609 260-265 JJ denotes human
T610 266-273 NN denotes disease
T611 274-276 VBZ denotes is
T612 277-283 RB denotes seldom
T590 284-294 VBN denotes considered
T613 294-295 . denotes .
T614 295-623 sentence denotes Evidence of interallelic complementation at clinically relevant loci is limited to biochemical and cell-based studies of a handful of metabolic disorders with defects in enzymes including propinyl-CoA carboxylase [2], argininosuccinate lyase [3], galactose-1-phosphate uridylyltransferase [4], and methylmalonyl CoA mutase [5].
T615 296-304 NN denotes Evidence
T617 305-307 IN denotes of
T618 308-320 JJ denotes interallelic
T619 321-336 NN denotes complementation
T620 337-339 IN denotes at
T621 340-350 RB denotes clinically
T622 351-359 JJ denotes relevant
T623 360-364 NNS denotes loci
T624 365-367 VBZ denotes is
T616 368-375 VBN denotes limited
T625 376-378 IN denotes to
T626 379-390 JJ denotes biochemical
T628 391-394 CC denotes and
T629 395-399 NN denotes cell
T631 399-400 HYPH denotes -
T630 400-405 VBN denotes based
T627 406-413 NNS denotes studies
T632 414-416 IN denotes of
T633 417-418 DT denotes a
T634 419-426 NN denotes handful
T635 427-429 IN denotes of
T636 430-439 JJ denotes metabolic
T637 440-449 NNS denotes disorders
T638 450-454 IN denotes with
T639 455-462 NNS denotes defects
T640 463-465 IN denotes in
T641 466-473 NNS denotes enzymes
T642 474-483 VBG denotes including
T643 484-492 NN denotes propinyl
T645 492-493 HYPH denotes -
T644 493-496 NN denotes CoA
T646 497-508 NN denotes carboxylase
T647 509-510 -LRB- denotes [
T648 510-511 CD denotes 2
T649 511-512 -RRB- denotes ]
T650 512-514 , denotes ,
T651 514-531 NN denotes argininosuccinate
T652 532-537 NN denotes lyase
T653 538-539 -LRB- denotes [
T654 539-540 CD denotes 3
T655 540-541 -RRB- denotes ]
T656 541-543 , denotes ,
T657 543-552 NN denotes galactose
T659 552-553 HYPH denotes -
T660 553-554 CD denotes 1
T661 554-555 HYPH denotes -
T658 555-564 NN denotes phosphate
T662 565-584 NN denotes uridylyltransferase
T663 585-586 -LRB- denotes [
T664 586-587 CD denotes 4
T665 587-588 -RRB- denotes ]
T666 588-590 , denotes ,
T667 590-593 CC denotes and
T668 594-607 NN denotes methylmalonyl
T670 608-611 NN denotes CoA
T669 612-618 NN denotes mutase
T671 619-620 -LRB- denotes [
T672 620-621 CD denotes 5
T673 621-622 -RRB- denotes ]
T674 622-623 . denotes .
R246 T565 T566 amod Interallelic,complementation
R247 T566 T567 nsubjpass complementation,defined
R248 T568 T567 auxpass is,defined
R249 T569 T567 prep as,defined
R250 T570 T571 det the,ability
R251 T571 T569 pobj ability,as
R252 T572 T571 prep of,ability
R253 T573 T574 nummod two,alleles
R254 T574 T572 pobj alleles,of
R255 T575 T576 advmod differentially,mutated
R256 T576 T574 amod mutated,alleles
R257 T577 T578 aux to,function
R258 T578 T571 acl function,ability
R259 T579 T578 advmod better,function
R260 T580 T578 advmod together,function
R261 T581 T582 mark than,can
R262 T582 T578 advcl can,function
R263 T583 T582 nsubj either,can
R264 T584 T582 prep on,can
R265 T585 T586 poss its,own
R266 T586 T584 pobj own,on
R267 T587 T567 punct .,defined
R268 T589 T590 prep Despite,considered
R269 T591 T592 poss its,universality
R270 T592 T589 pobj universality,Despite
R271 T593 T592 amod near,universality
R272 T594 T592 prep in,universality
R273 T595 T596 amod lower,organisms
R274 T596 T594 pobj organisms,in
R275 T597 T598 punct [,1
R276 T598 T596 parataxis 1,organisms
R277 T599 T598 punct ],1
R278 T600 T590 punct ", ",considered
R279 T601 T602 poss its,potential
R280 T602 T590 nsubjpass potential,considered
R281 T603 T604 aux to,contribute
R282 T604 T602 acl contribute,potential
R283 T605 T604 prep to,contribute
R284 T606 T607 amod clinical,heterogeneity
R285 T607 T605 pobj heterogeneity,to
R286 T608 T607 prep in,heterogeneity
R287 T609 T610 amod human,disease
R288 T610 T608 pobj disease,in
R289 T611 T590 auxpass is,considered
R290 T612 T590 advmod seldom,considered
R291 T613 T590 punct .,considered
R292 T615 T616 nsubjpass Evidence,limited
R293 T617 T615 prep of,Evidence
R294 T618 T619 amod interallelic,complementation
R295 T619 T617 pobj complementation,of
R296 T620 T619 prep at,complementation
R297 T621 T622 advmod clinically,relevant
R298 T622 T623 amod relevant,loci
R299 T623 T620 pobj loci,at
R300 T624 T616 auxpass is,limited
R301 T625 T616 prep to,limited
R302 T626 T627 amod biochemical,studies
R303 T627 T625 pobj studies,to
R304 T628 T626 cc and,biochemical
R305 T629 T630 npadvmod cell,based
R306 T630 T626 conj based,biochemical
R307 T631 T630 punct -,based
R308 T632 T627 prep of,studies
R309 T633 T634 det a,handful
R310 T634 T632 pobj handful,of
R311 T635 T634 prep of,handful
R312 T636 T637 amod metabolic,disorders
R313 T637 T635 pobj disorders,of
R314 T638 T637 prep with,disorders
R315 T639 T638 pobj defects,with
R316 T640 T639 prep in,defects
R317 T641 T640 pobj enzymes,in
R318 T642 T641 prep including,enzymes
R319 T643 T644 compound propinyl,CoA
R320 T644 T646 compound CoA,carboxylase
R321 T645 T644 punct -,CoA
R322 T646 T642 pobj carboxylase,including
R323 T647 T648 punct [,2
R324 T648 T646 parataxis 2,carboxylase
R325 T649 T648 punct ],2
R326 T650 T646 punct ", ",carboxylase
R327 T651 T652 compound argininosuccinate,lyase
R328 T652 T646 conj lyase,carboxylase
R329 T653 T654 punct [,3
R330 T654 T652 parataxis 3,lyase
R331 T655 T654 punct ],3
R332 T656 T652 punct ", ",lyase
R333 T657 T658 nmod galactose,phosphate
R334 T658 T662 compound phosphate,uridylyltransferase
R335 T659 T658 punct -,phosphate
R336 T660 T658 nummod 1,phosphate
R337 T661 T658 punct -,phosphate
R338 T662 T652 conj uridylyltransferase,lyase
R339 T663 T664 punct [,4
R340 T664 T662 parataxis 4,uridylyltransferase
R341 T665 T664 punct ],4
R342 T666 T662 punct ", ",uridylyltransferase
R343 T667 T662 cc and,uridylyltransferase
R344 T668 T669 compound methylmalonyl,mutase
R345 T669 T662 conj mutase,uridylyltransferase
R346 T670 T669 compound CoA,mutase
R347 T671 T672 punct [,5
R348 T672 T669 parataxis 5,mutase
R349 T673 T672 punct ],5
R350 T674 T616 punct .,limited